Previously published reports demonstrated the involvement of abnormal c‐Met signalling in several oncogenic pathways such as proliferation, invasion and angiogenesis; and it has been indicated as an independent prognostic factor for the worst outcome in many cancers.17, 20, 21, 22. The gene discussed is MET; the disease is cancer.